Header cover image
  • Investing Ideas
  • Spanish Pharmaceuticals & Biotech Undervalued based on future growth

Spanish Pharmaceuticals & Biotech Undervalued based on future growth

Results

1

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

Labiana Health

Market Cap: €30.8m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally.

LAB

€4.40

7D

-3.1%

1Y

51.7%